Works matching DE "THERAPEUTIC use of monoclonal antibodies"
Results: 5000
Real-world characteristics and outcomes of ERBB2-mutant NSCLC in Latin American patients (CLICaP).
- Published in:
- Oncologist, 2025, v. 30, n. 2, p. 1, doi. 10.1093/oncolo/oyae347
- By:
- Publication type:
- Article
Phase Ib study of anti-PD-L1 monoclonal antibody socazolimab in combination with nab-paclitaxel as first-line therapy for advanced urothelial carcinoma.
- Published in:
- Oncologist, 2025, v. 30, n. 2, p. 1, doi. 10.1093/oncolo/oyae260
- By:
- Publication type:
- Article
Molecular characterization of metastatic penile squamous cell carcinoma in developing countries and its impact on clinical outcomes: LACOG 2018 translational study.
- Published in:
- Oncologist, 2025, v. 30, n. 2, p. 1, doi. 10.1093/oncolo/oyae220
- By:
- Publication type:
- Article
Efficacy and continuability of 675 mg fremanezumab administration over 2 years.
- Published in:
- Journal of Headache & Pain, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s10194-025-01994-5
- By:
- Publication type:
- Article
Ebronucimab: First Approval: Ebronucimab: First Approval: H. A. Blair.
- Published in:
- Drugs, 2025, v. 85, n. 3, p. 437, doi. 10.1007/s40265-025-02146-4
- By:
- Publication type:
- Article
The Expanding Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Armamentarium: The Expanding AAV Armamentarium: D. P. McGovern et al.
- Published in:
- Drugs, 2025, v. 85, n. 3, p. 325, doi. 10.1007/s40265-024-02143-z
- By:
- Publication type:
- Article
Targeting HER2 in Gastroesophageal Cancer: A New Appetite for an Old Plight: Targeting HER2 in Gastroesophageal Cancer: A. Cammarota et al.
- Published in:
- Drugs, 2025, v. 85, n. 3, p. 361, doi. 10.1007/s40265-024-02132-2
- By:
- Publication type:
- Article
Response to Dr Ahmed and Dr Farooqi: Eculizumab versus plasma exchange for pediatric anti-FH antibody-associated atypical hemolytic uremic syndrome.
- Published in:
- 2025
- By:
- Publication type:
- Letter
Eculizumab for pediatric anti-FH antibody-associated atypical hemolytic uremic syndrome: promising results but critical gaps remain.
- Published in:
- 2025
- By:
- Publication type:
- Letter to the Editor
Eculizumab as first-line treatment for patients with severe presentation of complement factor H antibody–mediated hemolytic uremic syndrome.
- Published in:
- Pediatric Nephrology, 2025, v. 40, n. 4, p. 1041, doi. 10.1007/s00467-024-06530-2
- By:
- Publication type:
- Article
Researchers Develop Antibody-Toxin Conjugate for Enhanced Cancer Immunotherapy.
- Published in:
- Indian Practitioner, 2025, v. 78, n. 2, p. 41
- Publication type:
- Article
Survival with trastuzumab emtansine in residual HER2-positive breast cancer.
- Published in:
- Breast Cancer Research Review, 2025, n. 46, p. 5
- By:
- Publication type:
- Article
Overall survival with pembrolizumab in early-stage triple-negative breast cancer.
- Published in:
- Breast Cancer Research Review, 2025, n. 46, p. 5
- By:
- Publication type:
- Article
Complete Response to Immunotherapy in Patients With Hepatocellular Carcinoma.
- Published in:
- JAMA Network Open, 2025, v. 8, n. 2, p. e2461735, doi. 10.1001/jamanetworkopen.2024.61735
- By:
- Publication type:
- Article
Enfortumab Vedotin Plus Pembrolizumab Compared to Pembrolizumab and Standard Chemotherapy: Birds of a Feather Flock Together in Urothelial Cancer.
- Published in:
- 2025
- By:
- Publication type:
- Editorial
Predictive Value of Circulatory Total VEGF-A and VEGF-A Isoforms for the Efficacy of Anti-PD-1/PD-L1 Antibodies in Patients with Non-Small-Cell Lung Cancer.
- Published in:
- Cancers, 2025, v. 17, n. 4, p. 572, doi. 10.3390/cancers17040572
- By:
- Publication type:
- Article
Pilot Study on the Efficacy of a Novel Questionnaire for Assessing Psychological Health in Patients with Chronic Rhinosinusitis with Nasal Polyps Treated with Biologics.
- Published in:
- Healthcare (2227-9032), 2025, v. 13, n. 4, p. 433, doi. 10.3390/healthcare13040433
- By:
- Publication type:
- Article
Anti-Spike Monoclonal Antibody Monotherapies and Immune Escape Risk Minimization Strategies.
- Published in:
- 2025
- By:
- Publication type:
- Letter to the Editor
In Reply to Letter From Parkash and Smith.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2025, v. 149, n. 3, p. 208, doi. 10.5858/arpa.2024-0417-LE
- By:
- Publication type:
- Article
Development of an FRα Companion Diagnostic Immunohistochemical Assay for Mirvetuximab Soravtansine.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2025, v. 149, n. 3, p. 207, doi. 10.5858/arpa.2024-0277-LE
- By:
- Publication type:
- Article
Severe Asthma in School-Age Children: An Updated Appraisal on Biological Options and Challenges in This Age Group.
- Published in:
- Children, 2025, v. 12, n. 2, p. 167, doi. 10.3390/children12020167
- By:
- Publication type:
- Article
Diagnosing rashes, part 8: Psoriasis.
- Published in:
- Practice Nursing, 2014, v. 25, n. 3, p. 136, doi. 10.12968/pnur.2014.25.3.136
- By:
- Publication type:
- Article
Correction: Rozanolixizumab in generalized myasthenia gravis: a profile of its use.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Mirikizumab in moderately to severely active ulcerative colitis: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 11, p. 433, doi. 10.1007/s40267-024-01114-4
- By:
- Publication type:
- Article
Lecanemab in Alzheimer's disease: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 10, p. 393, doi. 10.1007/s40267-024-01108-2
- By:
- Publication type:
- Article
Adis summary of research: Omalizumab in severe asthma: effect on oral corticosteroid exposure and remodelling. A randomized open-label parallel study.
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 8, p. 291, doi. 10.1007/s40267-024-01083-8
- By:
- Publication type:
- Article
Rozanolixizumab in generalized myasthenia gravis: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 6, p. 203, doi. 10.1007/s40267-024-01077-6
- By:
- Publication type:
- Article
Aim to alleviate alopecia areata with newly available agents.
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 5, p. 181, doi. 10.1007/s40267-024-01069-6
- By:
- Publication type:
- Article
Mirvetuximab soravtansine in folate receptor alpha-positive, platinum-resistant ovarian cancers: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 2, p. 53, doi. 10.1007/s40267-024-01050-3
- By:
- Publication type:
- Article
Correction to: Tezepelumab in severe asthma: a profile of its use.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Nirsevimab in the prevention of respiratory syncytial virus lower respiratory tract disease: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 12, p. 413, doi. 10.1007/s40267-023-01039-4
- By:
- Publication type:
- Article
The PHASTER Study: Economic and Organizational Impact of Subcutaneous (SC) Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Treatment of HER2+ Breast Cancer Patients.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 12, p. 432, doi. 10.1007/s40267-023-01038-5
- By:
- Publication type:
- Article
Spesolimab in generalised pustular psoriasis flares: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 12, p. 404, doi. 10.1007/s40267-023-01034-9
- By:
- Publication type:
- Article
Tezepelumab in severe asthma: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 12, p. 393, doi. 10.1007/s40267-023-01033-w
- By:
- Publication type:
- Article
Ublituximab in relapsing forms of multiple sclerosis: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 11, p. 365, doi. 10.1007/s40267-023-01030-z
- By:
- Publication type:
- Article
Consider new therapies for the treatment and prevention of Clostridioides difficile infection.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 7, p. 237, doi. 10.1007/s40267-023-01006-z
- By:
- Publication type:
- Article
Calcitonin gene-related peptide-targeted therapies are effective options for the prevention and treatment of migraine.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 6, p. 195, doi. 10.1007/s40267-023-00995-1
- By:
- Publication type:
- Article
Nivolumab/relatlimab in advanced melanoma: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 3, p. 89, doi. 10.1007/s40267-023-00980-8
- By:
- Publication type:
- Article
Aducanumab: a review of the first approved amyloid-targeting antibody for Alzheimer's disease.
- Published in:
- Drugs & Therapy Perspectives, 2022, v. 38, n. 10, p. 443, doi. 10.1007/s40267-022-00944-4
- By:
- Publication type:
- Article
Tisotumab vedotin-tftv in previously treated recurrent or metastatic cervical cancer: a profile of its use in the USA.
- Published in:
- Drugs & Therapy Perspectives, 2022, v. 38, n. 9, p. 382, doi. 10.1007/s40267-022-00939-1
- By:
- Publication type:
- Article
Anifrolumab in systemic lupus erythematosus: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2022, v. 38, n. 7, p. 293, doi. 10.1007/s40267-022-00925-7
- By:
- Publication type:
- Article
Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma: a profile of its use in the USA.
- Published in:
- Drugs & Therapy Perspectives, 2022, v. 38, n. 6, p. 261, doi. 10.1007/s40267-022-00922-w
- By:
- Publication type:
- Article
Targeted therapy for metastatic colorectal cancer: what do we currently have in clinical practice?
- Published in:
- Drugs & Therapy Perspectives, 2022, v. 38, n. 5, p. 222, doi. 10.1007/s40267-022-00915-9
- By:
- Publication type:
- Article
Emerging small molecule antivirals may fit neatly into COVID-19 treatment.
- Published in:
- Drugs & Therapy Perspectives, 2022, v. 38, n. 3, p. 112, doi. 10.1007/s40267-022-00897-8
- By:
- Publication type:
- Article
Development and characterization of monoclonal antibodies to subgroup A avian leukosis virus.
- Published in:
- Veterinary & Comparative Oncology, 2014, v. 12, n. 1, p. 47, doi. 10.1111/vco.12036
- By:
- Publication type:
- Article
Progress in the Management of Pregnancy with Paroxysmal Nocturnal Hemoglobinuria: A Review.
- Published in:
- Journal of Women's Health (15409996), 2024, v. 33, n. 1, p. 98, doi. 10.1089/jwh.2023.0164
- By:
- Publication type:
- Article
Osteoporosis Management.
- Published in:
- Journal of Women's Health (15409996), 2020, v. 29, n. 3, p. 287, doi. 10.1089/jwh.2019.8195
- By:
- Publication type:
- Article
Postmenopausal Osteoporosis: A Clinical Review.
- Published in:
- Journal of Women's Health (15409996), 2018, v. 27, n. 9, p. 1093, doi. 10.1089/jwh.2017.6706
- By:
- Publication type:
- Article
Osteoporosis Management.
- Published in:
- Journal of Women's Health (15409996), 2017, v. 26, n. 8, p. 918, doi. 10.1089/jwh.2017.6496
- By:
- Publication type:
- Article
Efficacy of erenumab and factors predicting response after 3 months in treatment resistant chronic migraine: a clinical service evaluation.
- Published in:
- Journal of Headache & Pain, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s10194-022-01456-2
- By:
- Publication type:
- Article